Company news

InspireMD Inc. news in 2026

InspireMD Inc.'s news releases, calls and decks from 2026, newest first.

View company

InspireMD to Announce Third Quarter 2026 Financial Results

October 29, 2026

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

September 21, 2026

InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference

September 3, 2026

InspireMD Reports Second Quarter 2026 Financial Results

August 17, 2026

InspireMD to Announce Second Quarter 2026 Financial Results

August 10, 2026

InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing

July 30, 2026

InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures

June 11, 2026

InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures

June 8, 2026

InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference

May 6, 2026

InspireMD Reports First Quarter 2026 Financial Results

May 4, 2026

InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System

May 1, 2026

InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

May 1, 2026

InspireMD to Announce First Quarter 2026 Financial Results

April 27, 2026

InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference

March 31, 2026

InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results

March 17, 2026

InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results

March 9, 2026

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 20, 2026

InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)

January 12, 2026

Calls in 2026

Decks in 2026